Iguana Healthcare Management
Latest statistics and disclosures from Iguana Healthcare Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Spdr S&p 500 Etf Tr option, ESPR, Immunomedics, Global Blood Therapeutics In, HUM, and represent 24.45% of Iguana Healthcare Management's stock portfolio.
- Added to shares of these 10 stocks: Spdr S&p 500 Etf Tr option (+$13M), Shire, Esperion Therapeutics Inc Ne, CNC, Alexion Pharmaceuticals, Laboratory Corp. of America Holdings, DXCM, Catalyst Biosciences, Zosano Pharma Corp, RCKT.
- Started 25 new stock positions in Affimed Therapeutics B V, Solid Biosciences, Zosano Pharma Corp, Spectrum Pharmaceuticals, ARWR, Spdr S&p Oil & Gas Exp & Pr put, Mirati Therapeutics, IOVA, DXCM, Shire.
- Reduced shares in these 10 stocks: Celgene Corporation (-$7.8M), Aerie Pharmaceuticals (-$5.1M), , ESPR, K2m Group Holdings, Juno Therapeutics, ZBH, Intersect Ent, KPTI, DHR.
- Sold out of its positions in ABBV, Ablynx Nv, Aerie Pharmaceuticals, Akcea Therapeutics Inc equities, Avexis, BSX, Celgene Corporation, Chemocentryx, Clovis Oncology, DHR. Intersect Ent, IONS, Juno Therapeutics, LHC, Newlink Genetics, PFE, PBYI, RGNX, SUPN, Transenterix, ZBH, Allergan, Wright Medical Group Nv, WVE.
- Iguana Healthcare Management was a net seller of stock by $-1.1M.
- Iguana Healthcare Management has $152M in assets under management (AUM), dropping by -1.00%.
- Central Index Key (CIK): 0001597549
Tip: Access up to 7 years of quarterly data
Positions held by Iguana Healthcare Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Iguana Healthcare Management
Iguana Healthcare Management holds 62 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr option | 8.7 | $13M | NEW | 50k | 263.16 |
|
| Esperion Therapeutics (ESPR) | 4.8 | $7.2M | -39% | 100k | 72.33 |
|
| Immunomedics | 3.8 | $5.8M | -11% | 400k | 14.61 |
|
| Global Blood Therapeutics In | 3.6 | $5.6M | -8% | 115k | 48.30 |
|
| Humana (HUM) | 3.5 | $5.4M | -11% | 20k | 268.85 |
|
| Biogen Idec (BIIB) | 3.1 | $4.8M | -20% | 18k | 273.83 |
|
| Merck & Co (MRK) | 2.9 | $4.4M | 80k | 54.48 |
|
|
| Arena Pharmaceuticals | 2.6 | $4.0M | +100% | 100k | 39.50 |
|
| Shire | 2.5 | $3.7M | NEW | 25k | 149.40 |
|
| Clovis Oncology | 2.4 | $3.7M | +16% | 70k | 52.80 |
|
| Esperion Therapeutics Inc Ne | 2.4 | $3.6M | NEW | 50k | 72.34 |
|
| Anaptysbio Inc Common (ANAB) | 2.2 | $3.4M | -18% | 33k | 104.09 |
|
| CIGNA Corporation | 2.2 | $3.4M | -20% | 20k | 167.75 |
|
| Mylan Nv | 2.2 | $3.3M | +100% | 80k | 41.18 |
|
| Centene Corporation (CNC) | 2.1 | $3.2M | NEW | 30k | 106.87 |
|
| Bristol Myers Squibb (BMY) | 2.1 | $3.2M | 50k | 63.26 |
|
|
| Alexion Pharmaceuticals | 2.0 | $3.1M | NEW | 28k | 111.45 |
|
| Ultragenyx Pharmaceutical (RARE) | 2.0 | $3.1M | +20% | 60k | 50.98 |
|
| Abbott Laboratories (ABT) | 2.0 | $3.0M | -33% | 50k | 59.92 |
|
| Laboratory Corp. of America Holdings | 1.9 | $2.8M | NEW | 18k | 161.77 |
|
| Adma Biologics (ADMA) | 1.8 | $2.8M | 600k | 4.60 |
|
|
| Dex (DXCM) | 1.7 | $2.6M | NEW | 35k | 74.17 |
|
| Catalyst Biosciences | 1.7 | $2.6M | NEW | 100k | 25.80 |
|
| Tesaro | 1.7 | $2.6M | +28% | 45k | 57.13 |
|
| Zosano Pharma Corp | 1.7 | $2.5M | NEW | 500k | 5.04 |
|
| Sangamo Biosciences (SGMO) | 1.6 | $2.4M | -16% | 125k | 19.00 |
|
| GlaxoSmithKline | 1.5 | $2.3M | +100% | 60k | 39.07 |
|
| Rocket Pharmaceuticals (RCKT) | 1.5 | $2.3M | NEW | 125k | 18.75 |
|
| Medicines Company | 1.5 | $2.3M | +16% | 70k | 32.94 |
|
| Armo Biosciences Ord | 1.5 | $2.2M | NEW | 60k | 37.42 |
|
| Spdr S&p Oil & Gas Exp & Pr put | 1.4 | $2.2M | NEW | 25k | 87.72 |
|
| Sierra Oncology | 1.4 | $2.1M | +25% | 1.0M | 2.07 |
|
| Diplomat Pharmacy | 1.3 | $2.0M | +100% | 100k | 20.15 |
|
| Myokardia | 1.3 | $2.0M | -20% | 40k | 48.80 |
|
| Cytomx Therapeutics (CTMX) | 1.2 | $1.8M | -13% | 65k | 28.45 |
|
| Mirati Therapeutics | 1.1 | $1.7M | NEW | 55k | 30.71 |
|
| Iovance Biotherapeutics (IOVA) | 1.1 | $1.7M | NEW | 100k | 16.90 |
|
| Karyopharm Therapeutics (KPTI) | 1.1 | $1.7M | -58% | 125k | 13.42 |
|
| Viking Therapeutics (VKTX) | 1.1 | $1.6M | +66% | 375k | 4.37 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.9 | $1.4M | NEW | 200k | 7.21 |
|
| Merus N V (MRUS) | 0.9 | $1.4M | -25% | 75k | 18.53 |
|
| Voyager Therapeutics (VYGR) | 0.9 | $1.3M | +40% | 70k | 18.79 |
|
| Achaogen | 0.8 | $1.3M | +33% | 100k | 12.95 |
|
| Corium Intl | 0.8 | $1.3M | +22% | 110k | 11.47 |
|
| Incyte Corporation (INCY) | 0.8 | $1.2M | +50% | 15k | 83.33 |
|
| Catalent (CTLT) | 0.8 | $1.2M | 30k | 41.07 |
|
|
| Cerner Corporation | 0.8 | $1.2M | NEW | 20k | 58.00 |
|
| Adverum Biotechnologies | 0.8 | $1.2M | 200k | 5.80 |
|
|
| Xencor (XNCR) | 0.7 | $1.0M | NEW | 35k | 29.97 |
|
| Kura Oncology (KURA) | 0.6 | $938k | NEW | 50k | 18.76 |
|
| Seattle Genetics | 0.6 | $916k | NEW | 18k | 52.34 |
|
| Spectrum Pharmaceuticals | 0.5 | $805k | NEW | 50k | 16.10 |
|
| Dermira | 0.5 | $799k | 100k | 7.99 |
|
|
| Assembly Biosciences | 0.5 | $737k | NEW | 15k | 49.13 |
|
| Adamas Pharmaceuticals | 0.5 | $717k | NEW | 30k | 23.90 |
|
| Exelixis (EXEL) | 0.4 | $665k | NEW | 30k | 22.17 |
|
| Affimed Therapeutics B V | 0.4 | $555k | NEW | 300k | 1.85 |
|
| Scynexis | 0.3 | $536k | +60% | 400k | 1.34 |
|
| Oncomed Pharmaceuticals | 0.3 | $477k | 150k | 3.18 |
|
|
| K2m Group Holdings | 0.3 | $474k | -85% | 25k | 18.96 |
|
| Marinus Pharmaceuticals | 0.2 | $382k | 100k | 3.82 |
|
|
| Solid Biosciences | 0.2 | $375k | NEW | 50k | 7.50 |
|
Past Filings by Iguana Healthcare Management
SEC 13F filings are viewable for Iguana Healthcare Management going back to 2013
- Iguana Healthcare Management 2018 Q1 filed May 15, 2018
- Iguana Healthcare Management 2017 Q4 filed Feb. 14, 2018
- Iguana Healthcare Management 2017 Q3 amended filed Nov. 16, 2017
- Iguana Healthcare Management 2017 Q3 filed Nov. 14, 2017
- Iguana Healthcare Management 2017 Q2 filed Aug. 14, 2017
- Iguana Healthcare Management 2017 Q1 filed May 15, 2017
- Iguana Healthcare Management 2016 Q4 filed Feb. 14, 2017
- Iguana Healthcare Management 2016 Q3 amended filed Nov. 17, 2016
- Iguana Healthcare Management 2016 Q3 filed Nov. 14, 2016
- Iguana Healthcare Management 2016 Q2 restated filed Nov. 4, 2016
- Iguana Healthcare Management 2016 Q2 filed Aug. 15, 2016
- Iguana Healthcare Management 2016 Q1 restated filed May 24, 2016
- Iguana Healthcare Management 2016 Q1 filed May 17, 2016
- Iguana Healthcare Management 2015 Q4 filed Feb. 16, 2016
- Iguana Healthcare Management 2015 Q3 filed Nov. 16, 2015
- Iguana Healthcare Management 2015 Q2 filed Aug. 14, 2015